Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 5 49-5, 2004, Pages

  Davidoff, Amy J ^a   Mason, Meredith M ^a   Davidson, Michael B ^a   Carmody, Marybeth W ^a   Hintz, Kadon K ^b   Wold, Loren E ^b   Podolin, Deborah A ^a   Ren, Jun ^b,c  

^a UNIVERSITY OF NEW ENGLAND   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Exercise; Fibrates; Fish oil; Type 2 diabetes

Indexed keywords

BEZAFIBRATE; DRINKING WATER; INSULIN; MENHADEN OIL; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; EXERCISE; FUNCTIONAL DISEASE; GLUCOSE TOLERANCE TEST; HEART MUSCLE CELL; HEART VENTRICLE WALL; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANTILIPEMIC AGENTS; BEZAFIBRATE; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; EXERTION; HEART DISEASES; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR;

EID: 1942486761     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00358.2003     Document Type: Article

References (45)

1. Baltzell JK, Jenkins RL, Wooten JT, and Otto DA. Dependence of the plasma triacylglycerol-lowering effect of fish oil on insulin replacement in streptozotocin diabetic rats. Biochim Biophys Acta 1167: 197-203, 1993.
2. Bloomgarden Z. Cardiovascular disease and diabetes. Diabetes Care 26: 230-237, 2003.
3. Cortez MY, Torgan CE, Brozinick JT Jr, and Ivy JL. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 261: E613-E619, 1991.
4. Dai S and McNeill JH. Effects of fructose loading in streptozotocin-diabetic and nondiabetic rats. Can J Physiol Pharmacol 70: 1583-1589, 1992.
5. Dallongeville J, Baugé E, Tailleux A, Peters JM, Gonzalez FJ, Fruchart J-C, and Staels B. Peroxisome proliferator-activated receptor a is not rate-limiting for the lipoprotein-lowering action of fish oil. J Biol Chem 276: 4634-4639, 2001.
6. DeBlieux PMC, Barbee RW, McDonough KH, and Shapherd RE. Exercise training improves cardiac performance in diabetic rats. Proc Soc Exp Biol Med 203: 209-213, 1993.
7. Diabetes Prevention Program Research Group. Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403, 2002.
8. Doenst T, Goodwin GW, Cedars AM, Wang M, Stepkowski S, and Taegtmeyer H. Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism 50: 1083-1090, 2001.
9. Dutta K, Carmody MW, Cala SE, and Davidoff AJ. Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J Mol Cell Cardiol 34: 985-996, 2002.
10. Dutta K, Podolin DA, Davidson MB, and Davidoff AJ. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50: 1186-1192, 2001.
11. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, Gross RW, and Kelly DP. A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 100: 1226-1231, 2003.
12. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, and Kelly DP. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Invest 109: 121-130, 2002.
13. Goa KL, Barradell LB, and Plosker GL. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia. Drugs 52: 725-753, 1996.
14. Grundy SM. N3 fatty acids. Priority for post-myocardial infarction clinical trials. Circulation 107: 1834-1836, 2003.
15. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, and Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100: 1134-1146, 1999.
16. Guay DR. Update on fenofibrate. Cardiovasc Drug Rev 20: 281-302, 2002.
17. Guerre-Millo M, Gervois P, Raspé E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart J-C, Berge RK, and Staels B. Peroxisome proliferator-activated receptor a activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275: 16638-16642, 2000.
18. Hamdy O, Goodyear LJ, and Horton ES. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am 30: 883-907, 2001.
19. Henriksen EJ. Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 93: 788-796, 2002.
20. 2+ exchange. FASEB J 14: A147.2, 2001.
21. Hu FB. The role of n-3 polyunsaturated fatty acids in the prevention and treatment of cardiovascular disease. Drugs Today 37: 49-56, 2001.
22. Li S, Culver B, and Ren J. Benefit and risk of exercise on myocardial function in diabetes. Pharmacol Res 48: 127-132, 2003.
23. Misra T, Gilchrist JSC, Russell JC, and Pierce GN. Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats. Am J Physiol Heart Circ Physiol 276: H1811-H1817, 1999.
24. Pagliassotti MJ and Prach PA. Quantity of sucrose alters the tissue pattern and time course of insulin resistance in young rats. Am J Physiol Regul Integr Comp Physiol 269: R641-R646, 1995.
25. Pagliassotti MJ, Prach PA, Koppenhafer TA, and Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol Regul Integr Comp Physiol 271: R1319-R1326, 1996.
26. Paulson DJ, Kopp SJ, Peace DG, and Tow JP. Myocardial adaptation to endurance exercise training in diabetic rats. Am J Physiol Regul Integr Comp Physiol 252: R1073-R1081, 1987.
27. Pierce GN, Maddaford TG, and Russell JC. Cardiovascular dysfunction in insulin-dependent and non-insulin-dependent animal models of diabetes mellitus. Can J Physiol Pharmacol 75: 343-350, 1997.
28. Podolin DA, Gayles EC, Wei Y, Thresher JS, and Pagliassotti MJ. Menhaden oil prevents but not reverse sucrose-induced insulin resistance in rats. Am J Physiol Regul Integr Comp Physiol 274: R840-R848, 1998.
29. Podolin DA, Wei Y, and Pagliassotti MJ. Effects of a high-fat diet and voluntary wheel running on gluconeogenesis and lipolysis in rats. J Appl Physiol 86: 1374-1380, 1999.
30. Ren J and Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol Heart Circ Physiol 272: H148-H158, 1997.
31. Ren J, Gintant GA, Miller RE, and Davidoff AJ. High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol Heart Circ Physiol 273: H2876-H2883, 1997.
32. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, Nesto RW, Wilson RWF, and Vasan RS. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107: 448-454, 2003.
33. Sakamoto K and Goodyear LJ. Intracellular signaling in contracting skeletal muscle. J Appl Physiol 93: 369-383, 2002.
34. Schaffer SW and Mozafferi M. Abnormal mechanical function in diabetes: relation to myocardial calcium handling. Coron Artery Dis 7: 109-115, 1996.
35. Schannwell CM, Schneppenheim M, Perings S, Plehn G, and Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98: 33-39, 2002.
36. Schrauwen P, van Aggel-Leijssen DP, Hul G, Wagenmakers AJ, Vidal H, Saris WH, and van Baak MA. The effect of a 3-mo low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes 51: 2220-2226, 2002.
37. + currents in rat heart: role of insulin. J Physiol 507: 485-496, 1998.
38. + currents. Am J Physiol Heart Circ Physiol 279: H639-H649, 2000.
39. Si X, Webb C, and Richey JM. Bezafibrate, an anti-hypertriglyceridemic drug, attenuates vascular hyperresponsiveness and elevated blood pressure in fructose-induced hypertensive rats. Can J Physiol Pharmacol 77: 755-762, 1999.
40. Steinberger J and Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 107: 1448-1453, 2003.
41. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, and Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglycerides and w-3 fatty acids in muscle phospholipid. Diabetes 40: 420-427, 1991.
42. Thresher JS, Podolin DA, Wei Y, Mazzeo RS, and Pagliassotti MJ. Comparison of the effects of sucrose and fructose on insulin action and glucose tolerance. Am J Physiol Regul Integr Comp Physiol 279: R1334-R1340, 2000.
43. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, and Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350, 2001.
44. Verma S, Yao L, Dumont AS, and McNeill JH. Metformin treatment corrects vascular insulin resistance in hypertension. J Hypertens 18: 1445-1450, 2000.
45. Zierath JR. Exercise training-induced changes in insulin signaling in skeletal muscle. J Appl Physiol 93: 773-781, 2002.